T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TTOO
1401
DELISTED
T2 Biosystems, Inc
TTOO
| $7.59M | ﹤0.01% |
93
+22
| +31% | +$1.91M |
|
1402
US Physical Therapy
USPH
$1.2B
| $7.55M | ﹤0.01% |
137,800
+131,400
| +2,053% | +$6.51M |
|
1403
Paylocity
PCTY
$7.95B
| $7.53M | ﹤0.01% |
210,100
+400
| +0.2% | +$12.9K |
|
|
PDCO
1404
DELISTED
Patterson Companies, Inc.
PDCO
| $7.5M | ﹤0.01% |
154,270
+9,000
| +6% | +$429K |
|
1405
iShares MSCI India ETF
INDA
$6.57B
| $7.46M | ﹤0.01% |
246,300
+37,000
| +18% | +$1.13M |
|
1406
Nu Skin
NUS
$240M
| $7.38M | ﹤0.01% |
156,602
+15,755
| +11% | +$852K |
|
|
ESIO
1407
DELISTED
Electro Scientific Industries
ESIO
| $7.34M | ﹤0.01% |
1,393,630
-1,502,730
| -52% | -$8.54M |
|
|
ESPR
1408
DELISTED
Esperion Therapeutics
ESPR
| $7.3M | ﹤0.01% |
89,272
-35,372
| -28% | -$3.46M |
|
1409
Pitney Bowes
PBI
$2.29B
| $7.25M | ﹤0.01% |
348,581
+10,200
| +3% | +$230K |
|
|
I
1410
DELISTED
INTELSAT S. A.
I
| $7.22M | ﹤0.01% |
+728,190
| New | +$8.2M |
|
|
PATI
1411
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
| $7.21M | ﹤0.01% |
292,659
+1,050
| +0.4% | +$26.9K |
|
|
TYPE
1412
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $7.15M | ﹤0.01% |
296,720
-1,000
| -0.3% | -$28.2K |
|
|
AIRM
1413
DELISTED
Air Methods Corp
AIRM
| $7.13M | ﹤0.01% |
172,400
-21,200
| -11% | -$928K |
|
|
NHC.PRA
1414
DELISTED
NATIONAL HEALTHCARE CORP PFD CONV SER A (DE)
NHC.PRA
| $7.12M | ﹤0.01% |
463,873
-497,343
| -52% | -$7.74M |
|
1415
Wingstop
WING
$3.23B
| $7.11M | ﹤0.01% |
+250,300
| New | +$7.22M |
|
1416
American Water Works
AWK
$27.1B
| $7.08M | ﹤0.01% |
145,700
+3,000
| +2% | +$158K |
|
1417
AptarGroup
ATR
$8.39B
| $7.05M | ﹤0.01% |
110,560
-512,050
| -82% | -$32.7M |
|
|
AGU
1418
DELISTED
Agrium
AGU
| $7.01M | ﹤0.01% |
66,205
+61,805
| +1,405% | +$6.5M |
|
|
FLIR
1419
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $7M | ﹤0.01% |
227,190
-2,900
| -1% | -$90.2K |
|
1420
Hain Celestial
HAIN
$56M
| $6.99M | ﹤0.01% |
106,096
+6,096
| +6% | +$385K |
|
|
INFI
1421
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $6.91M | ﹤0.01% |
631,320
+8,600
| +1% | +$110K |
|
1422
Charter Communications
CHTR
$18.7B
| $6.87M | ﹤0.01% |
40,110
-34,850
| -46% | -$6.27M |
|
1423
CorVel
CRVL
$3.28B
| $6.76M | ﹤0.01% |
633,798
+21,600
| +4% | +$251K |
|
|
HABT
1424
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $6.72M | ﹤0.01% |
214,900
+800
| +0.4% | +$27.6K |
|
1425
Urban Outfitters
URBN
$6.59B
| $6.7M | ﹤0.01% |
191,370
+30,700
| +19% | +$1.19M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.